NCT04003844 - Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

November 22, 2019

Study Completion Date

November 22, 2019

Conditions

Kawasaki Disease

Interventions

DRUG

Immunoglobulin G

single dose of IGIV 10% (2 g/kg) administered intravenously for at least 12 hours

DRUG

Acetylsalicylic acid

Coadministration

Trial Locations (7)

Hallym University Sacred Heart Hospital, Anyang

Asan Medical Center, Seoul

Kyung Hee University Hospital at Gangdong, Seoul

Kyung Hee University Medical Center, Seoul

Severance Hospital, Seoul

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

Wonju Severance Christian Hospital, Wŏnju